Accès ouvert
2026
article
OpenAlex
Mariana Korber, Amparo M. Gallardo‐Moreno, Lidia Ferrer‐Tasies, María Coronada Fernández‐Calderón et autres
Accès ouvert
2026
article
OpenAlex
Mariana Köber, Amparo M. Gallardo‐Moreno, Lidia Ferrer‐Tasies, María Coronada Fernández‐Calderón et autres
The growing threat of antibiotic-resistant pathogens has intensified the demand for alternative antibacterial materials. Quatsomes-nanovesicles composed of cholesterol and quaternary ammonium surfactants (QAS)-emerge as promising candidates due to their intrinsic antimicrobial properties and tunable physicochemical characteristics. Here, we investigate the antibacterial activity …
es, de
(code pays fourni par la source)
2026
conference-paper
OpenAlex
David Piña Muñoz, Lidia Ferrer‐Tasies, Josep Merlo, Alba Córdoba et autres
2024
book-chapter
OpenAlex
Núria Pujol-Solé, Lidia Ferrer‐Tasies, Judit Tomsen-Melero, Agustín Carreño et autres
Nanovesicle-based nanopharmaceuticals are highly complex formulations whose efficacy and safety are highly dependent on their physico-chemical and biological characteristics, and even small deviations may result in altered pharmacokinetics, in vivo clearance, drug release kinetics and toxicity/safety profiling. While the exact set of …
es
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Marta Alcaina-Hernando, Ivana Malvacio, Ilaria Ferraboschi, Cristián Huck‐Iriart et autres
• Novel nanovesicles without animal-derived components have been developed. • These stable nanovesicles are formed by the self-assembly of β-sitosterol, lauryl glucoside and lauryl glucose carboxylate using the single-step DELOS methodology. • Tocopherol as a hydrophobic model molecule is efficiently loaded in …
es, it, dk
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Marta Alcaina-Hernando, Ivana Malvacio, Ilaria Ferraboschi, Cristián Huck‐Iriart et autres
us, it, es, dk
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Mariana Köber, Sílvia Illa‐Tuset, Lidia Ferrer‐Tasies, Evelyn Moreno‐Calvo et autres
HYPOTHESIS: Quatsome nanovesicles, formed through the self-assembly of cholesterol (CHOL) and cetyltrimethylammonium bromide (CTAB) in water, have shown long-term stability in terms of size and morphology, while at the same time exhibiting high CHOL-CTAB intermolecular binding energies. We hypothesize that CHOL/CTAB quatsomes …
es, it, dk, il
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Lídia Ballell‐Hosa, Elisabet González‐Mira, Héctor Santana, Judit Morlà‐Folch et autres
Topical delivery has received great attention due to its localized drug delivery, its patient compliance, and its low risk for side effects. Recent developments have focused on studying new drug delivery systems as a strategy for addressing the challenges of current topical …
es, cu
(code pays fourni par la source)
Accès ouvert
2022
review
OpenAlex
Jorge Berlanga‐Acosta, Jose Fernandez-Montequin, Héctor Santana-Milián, Calixto Valdes-Perez et autres
Diabetes mellitus remains as a pandemic disease, associated to progressive and irreversible complications including lower extremity ulcerations, derived from a predisposition to ischemia, neuropathy and an intrinsic wound healing failure. The molecular operators supporting wound chronicity remain elusive, but a local deficit …
cu, pe, es
(code pays fourni par la source)
2021
article
OpenAlex
Lidia Ferrer‐Tasies, Héctor Santana, Ingrid Cabrera‐Puig, Elisabet González‐Mira et autres
In article number 2000260, Jaume Veciana, Nora Ventosa and co-workers report a soft, reliable, and scalable method based on compressed CO2 for obtaining nanoconjugates of recombinant human epidermal growth factors and nanovesicles. These nanoconjugates exhibit appropriate physicochemical properties together with an antimicrobial …
Accès ouvert
2021
article
OpenAlex
Lidia Ferrer‐Tasies, Héctor Santana, Ingrid Cabrera‐Puig, Elisabet González‐Mira et autres
Abstract A multitude of microparticles and nanoparticles is developed to improve the delivery of different small drugs and large biomolecules, which are subject to several hindering biological barriers that limit their optimal biodistribution and therapeutic effects. Here, a soft, reliable, and scalable …
es, cu, dk
(code pays fourni par la source)
2019
article
OpenAlex
Guillem Vargas‐Nadal, Mónica Muñoz-Úbeda, Patricia Álamo, Montserrat Mitjans et autres
es, us
(code pays fourni par la source)